Archive | Cancer Research Society RSS for this section

Do you know a promising PostDoc who is ready to launch their career? CRS has launched a $160,000 Next Generation of Scientists Competition. (due April 28)

The Cancer Research Society is pleased to announce the launch its 2017 Scholarships for the Next Generation of Scientists competition, an initiative aiming at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.

Deadlines for submitting an application: April 28, 2017, 11:59 pm (EST).

Part 1: Postdoctoral Salary Award –  1 year* –  $40,000

One year postdoctoral salary award for a candidate finishing his/her fellowship. The candidate must have completed at least two years of postdoctoral training at the time he/she accepts the salary award.
* Possibility of extending Part 1 of this award for a maximum period of 6 months.

Part 2: Operating Grant  –   2 years – $120,000 ($60,000/year)

Operating grant award once the candidate has obtained a faculty position at a recognized Canadian institution.

For details and application instructions go to:


Congratulate Mark Gauthier, Trang Hoang, Bernard Jasmin and Jane McGlade–recipients of pediatric oncology operating grants funded in partnership with the Cancer Research Society

We are excited to announce the recipients of the 4 pediatric oncology grants funded in partnership with the Cancer Research Society (listed below).  These grants are each funded at $120,000 over 2 years, with C17 and CRS contributing equal funds, and are administered through the CRS.

  • Mark A Gauthier, Institut National de la Recherche Scientifique (INRS)–Second generation molecular sieving coatings using asparaginase for improved treatment of leukemia
  • Trang Hoang, Institute for Research in Immunology and Cancer/Université de Montréal–Effect of UM011997 on human T-acute lymphoblastic leukemia
  • Bernard Jasmin, University of Ottawa–Misregulation of the RNA-binding protein Staufen1 in Rhabdomyosarcoma: Impact for pathogenesis and as a novel therapeutic target
  • Jane McGlade, The Hospital for Sick Children–SLAP adaptor regulation of Cbl and tyrosine kinase signaling in leukemia

Additional information about the 2015 CRS Operating Grant Competition can be found at: